Mimedx Group annual debt-to-ebitda ratio
2014
2015
2016
2017
2018
2023
2024
2025
Mimedx Group Debt-to-EBITDA Ratio Growth & History (MDXG)
Mimedx Group's debt-to-ebitda ratio was 0.29 for fiscal 2025.
View full Mimedx Group company overviewMimedx Group annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.29 | −0.10 | −25.26% |
| 2024 | 2024-12-31 | 0.38 | −0.89 | −69.90% |
| 2023 | 2023-12-31 | 1.27 | — | — |
| 2018 | 2018-12-31 | 0.08 | 0.07 | +1291.27% |
| 2017 | 2017-12-31 | 0.01 | 0.01 | — |
| 2016 | 2016-12-31 | 0.00 | 0.00 | — |
| 2015 | 2015-12-31 | 0.00 | 0.00 | — |
| 2014 | 2014-12-31 | 0.00 | — | — |
Mimedx Group quarterly debt-to-ebitda ratio
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q4.18
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.72 | 0.34 | +90.08% |
| Q1 2026 | 2026-03-31 | 0.32 | 0.01 | +3.32% |
| Q4 2025 | 2025-12-31 | 0.29 | −0.10 | −25.26% |
| Q3 2025 | 2025-09-30 | 0.31 | 0.02 | +6.58% |
| Q2 2025 | 2025-06-30 | 0.38 | 0.09 | +30.78% |
| Q1 2025 | 2025-03-31 | 0.31 | −0.05 | −13.61% |
| Q4 2024 | 2024-12-31 | 0.38 | −0.89 | −69.90% |
| Q3 2024 | 2024-09-30 | 0.29 | −1.05 | −78.62% |
| Q2 2024 | 2024-06-30 | 0.29 | −2.35 | −89.04% |
| Q1 2024 | 2024-03-31 | 0.36 | — | — |
| Q4 2023 | 2023-12-31 | 1.27 | — | — |
| Q3 2023 | 2023-09-30 | 1.34 | — | — |
| Q2 2023 | 2023-06-30 | 2.64 | — | — |
| Q4 2018 | 2018-12-31 | 0.08 | 0.07 | +1291.27% |
| Q4 2017 | 2017-12-31 | 0.01 | 0.01 | — |
| Q3 2017 | 2017-09-30 | 0.00 | 0.00 | — |
| Q2 2017 | 2017-06-30 | 0.00 | 0.00 | — |
| Q1 2017 | 2017-03-31 | 0.00 | 0.00 | — |
| Q4 2016 | 2016-12-31 | 0.00 | 0.00 | — |
| Q3 2016 | 2016-09-30 | 0.00 | 0.00 | — |
| Q2 2016 | 2016-06-30 | 0.00 | 0.00 | — |
| Q1 2016 | 2016-03-31 | 0.00 | 0.00 | — |
| Q4 2015 | 2015-12-31 | 0.00 | 0.00 | — |
| Q3 2015 | 2015-09-30 | 0.00 | 0.00 | — |
| Q2 2015 | 2015-06-30 | 0.00 | — | — |
| Q1 2015 | 2015-03-31 | 0.00 | — | — |
| Q4 2014 | 2014-12-31 | 0.00 | — | — |
| Q3 2014 | 2014-09-30 | 0.00 | — | — |
Mimedx Group debt-to-ebitda ratio trends
Between the periods ended 2014-12-31 and 2025-12-31, Mimedx Group's debt-to-ebitda ratio increased from 0.00 to 0.29, a change of 0.29. The latest reported quarter, Q2 2026, shows 0.72.
About the metric
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
Calculation and source
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mimedx Group source filings ↗